Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection

In this trial, the safety and efficacy of a recombinant chimpanzee adenovirus 3 vector priming vaccination and a recombinant modified vaccinia Ankara boost was assessed in adults who were at risk for HCV infection because of injection drug use. The vaccine did not cause serious adverse events and di...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 2021-02, Vol.384 (6), p.541-549
Hauptverfasser: Page, Kimberly, Melia, Michael T, Veenhuis, Rebecca T, Winter, Matthew, Rousseau, Kimberly E, Massaccesi, Guido, Osburn, William O, Forman, Michael, Thomas, Elaine, Thornton, Karla, Wagner, Katherine, Vassilev, Ventzislav, Lin, Lan, Lum, Paula J, Giudice, Linda C, Stein, Ellen, Asher, Alice, Chang, Soju, Gorman, Richard, Ghany, Marc G, Liang, T. Jake, Wierzbicki, Michael R, Scarselli, Elisa, Nicosia, Alfredo, Folgori, Antonella, Capone, Stefania, Cox, Andrea L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 549
container_issue 6
container_start_page 541
container_title The New England journal of medicine
container_volume 384
creator Page, Kimberly
Melia, Michael T
Veenhuis, Rebecca T
Winter, Matthew
Rousseau, Kimberly E
Massaccesi, Guido
Osburn, William O
Forman, Michael
Thomas, Elaine
Thornton, Karla
Wagner, Katherine
Vassilev, Ventzislav
Lin, Lan
Lum, Paula J
Giudice, Linda C
Stein, Ellen
Asher, Alice
Chang, Soju
Gorman, Richard
Ghany, Marc G
Liang, T. Jake
Wierzbicki, Michael R
Scarselli, Elisa
Nicosia, Alfredo
Folgori, Antonella
Capone, Stefania
Cox, Andrea L
description In this trial, the safety and efficacy of a recombinant chimpanzee adenovirus 3 vector priming vaccination and a recombinant modified vaccinia Ankara boost was assessed in adults who were at risk for HCV infection because of injection drug use. The vaccine did not cause serious adverse events and did elicit HCV-specific T-cell responses, but it did not prevent chronic HCV infection.
doi_str_mv 10.1056/NEJMoa2023345
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8367093</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2488213174</sourcerecordid><originalsourceid>FETCH-LOGICAL-c511t-6e5052fd4d75fff5dd7ed17137cb3747bf3c6a3ffec249331c4463a2886ed55b3</originalsourceid><addsrcrecordid>eNp1kE1LAzEQhoMotlaPXiUgHleTnWSzvQhSWqvUD0S9hjQfNqWbaHZb0F_vSqvowbnMYR6eeXkROqTklBJenN0Or2-iykkOwPgW6lIOkDFGim3UJSQvMyb60EF7dT0n7VDW30UdAF4I2ocuGj2oYGLlP6zBj8mrBY4OK_ystPbB4gf74isbcBPxfbIrGxo8mKUYvMbjwTO-Cs7qxsewj3acWtT2YLN76Gk0fByMs8nd5dXgYpJpTmmTFZYTnjvDjODOOW6MsIYKCkJPQTAxdaALBa615qwPQDVjBai8LAtrOJ9CD52vva_LaWWNbgMltZCvyVcqvcuovPx7CX4mX-JKllAI0hp76HgjSPFtaetGzuMyhTazzFlZ5hSoYC2VrSmdYl0n634-UCK_apd_am_5o9-xfujvnlvgZA1UVS2DnVf_iD4BRTmI2Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2488213174</pqid></control><display><type>article</type><title>Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection</title><source>MEDLINE</source><source>New England Journal of Medicine Current</source><source>EZB Electronic Journals Library</source><creator>Page, Kimberly ; Melia, Michael T ; Veenhuis, Rebecca T ; Winter, Matthew ; Rousseau, Kimberly E ; Massaccesi, Guido ; Osburn, William O ; Forman, Michael ; Thomas, Elaine ; Thornton, Karla ; Wagner, Katherine ; Vassilev, Ventzislav ; Lin, Lan ; Lum, Paula J ; Giudice, Linda C ; Stein, Ellen ; Asher, Alice ; Chang, Soju ; Gorman, Richard ; Ghany, Marc G ; Liang, T. Jake ; Wierzbicki, Michael R ; Scarselli, Elisa ; Nicosia, Alfredo ; Folgori, Antonella ; Capone, Stefania ; Cox, Andrea L</creator><creatorcontrib>Page, Kimberly ; Melia, Michael T ; Veenhuis, Rebecca T ; Winter, Matthew ; Rousseau, Kimberly E ; Massaccesi, Guido ; Osburn, William O ; Forman, Michael ; Thomas, Elaine ; Thornton, Karla ; Wagner, Katherine ; Vassilev, Ventzislav ; Lin, Lan ; Lum, Paula J ; Giudice, Linda C ; Stein, Ellen ; Asher, Alice ; Chang, Soju ; Gorman, Richard ; Ghany, Marc G ; Liang, T. Jake ; Wierzbicki, Michael R ; Scarselli, Elisa ; Nicosia, Alfredo ; Folgori, Antonella ; Capone, Stefania ; Cox, Andrea L</creatorcontrib><description>In this trial, the safety and efficacy of a recombinant chimpanzee adenovirus 3 vector priming vaccination and a recombinant modified vaccinia Ankara boost was assessed in adults who were at risk for HCV infection because of injection drug use. The vaccine did not cause serious adverse events and did elicit HCV-specific T-cell responses, but it did not prevent chronic HCV infection.</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJMoa2023345</identifier><identifier>PMID: 33567193</identifier><language>eng</language><publisher>United States: Massachusetts Medical Society</publisher><subject>Adenoviruses, Simian - genetics ; Adolescent ; Adult ; Adverse events ; Allergies ; Animals ; Chronic infection ; Double-Blind Method ; Double-blind studies ; Enrollments ; Female ; Genetic Vectors ; Genotype &amp; phenotype ; Hepatitis C ; Hepatitis C Antibodies - blood ; Hepatitis C, Chronic - epidemiology ; Hepatitis C, Chronic - immunology ; Hepatitis C, Chronic - prevention &amp; control ; Humans ; Immunogenicity, Vaccine ; Incidence ; Infections ; Infectious diseases ; Laboratories ; Lymphocytes T ; Male ; Middle Aged ; Nonstructural proteins ; Pan troglodytes ; Peptides ; Placebos ; Ribonucleic acid ; RNA ; Substance Abuse, Intravenous ; T-Lymphocytes - immunology ; Vaccine efficacy ; Vaccines ; Vaccines, Synthetic - immunology ; Vaccinia ; Viral Hepatitis Vaccines - adverse effects ; Viral Hepatitis Vaccines - immunology ; Viral infections ; Viremia ; Young Adult</subject><ispartof>The New England journal of medicine, 2021-02, Vol.384 (6), p.541-549</ispartof><rights>Copyright © 2021 Massachusetts Medical Society. All rights reserved.</rights><rights>Copyright © 2021 Massachusetts Medical Society.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c511t-6e5052fd4d75fff5dd7ed17137cb3747bf3c6a3ffec249331c4463a2886ed55b3</citedby><cites>FETCH-LOGICAL-c511t-6e5052fd4d75fff5dd7ed17137cb3747bf3c6a3ffec249331c4463a2886ed55b3</cites><orcidid>0000-0003-3097-0289</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJMoa2023345$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.nejm.org/doi/full/10.1056/NEJMoa2023345$$EHTML$$P50$$Gmms$$H</linktohtml><link.rule.ids>230,314,776,780,881,2746,2747,26080,27901,27902,52357,54039</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33567193$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Page, Kimberly</creatorcontrib><creatorcontrib>Melia, Michael T</creatorcontrib><creatorcontrib>Veenhuis, Rebecca T</creatorcontrib><creatorcontrib>Winter, Matthew</creatorcontrib><creatorcontrib>Rousseau, Kimberly E</creatorcontrib><creatorcontrib>Massaccesi, Guido</creatorcontrib><creatorcontrib>Osburn, William O</creatorcontrib><creatorcontrib>Forman, Michael</creatorcontrib><creatorcontrib>Thomas, Elaine</creatorcontrib><creatorcontrib>Thornton, Karla</creatorcontrib><creatorcontrib>Wagner, Katherine</creatorcontrib><creatorcontrib>Vassilev, Ventzislav</creatorcontrib><creatorcontrib>Lin, Lan</creatorcontrib><creatorcontrib>Lum, Paula J</creatorcontrib><creatorcontrib>Giudice, Linda C</creatorcontrib><creatorcontrib>Stein, Ellen</creatorcontrib><creatorcontrib>Asher, Alice</creatorcontrib><creatorcontrib>Chang, Soju</creatorcontrib><creatorcontrib>Gorman, Richard</creatorcontrib><creatorcontrib>Ghany, Marc G</creatorcontrib><creatorcontrib>Liang, T. Jake</creatorcontrib><creatorcontrib>Wierzbicki, Michael R</creatorcontrib><creatorcontrib>Scarselli, Elisa</creatorcontrib><creatorcontrib>Nicosia, Alfredo</creatorcontrib><creatorcontrib>Folgori, Antonella</creatorcontrib><creatorcontrib>Capone, Stefania</creatorcontrib><creatorcontrib>Cox, Andrea L</creatorcontrib><title>Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>In this trial, the safety and efficacy of a recombinant chimpanzee adenovirus 3 vector priming vaccination and a recombinant modified vaccinia Ankara boost was assessed in adults who were at risk for HCV infection because of injection drug use. The vaccine did not cause serious adverse events and did elicit HCV-specific T-cell responses, but it did not prevent chronic HCV infection.</description><subject>Adenoviruses, Simian - genetics</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Adverse events</subject><subject>Allergies</subject><subject>Animals</subject><subject>Chronic infection</subject><subject>Double-Blind Method</subject><subject>Double-blind studies</subject><subject>Enrollments</subject><subject>Female</subject><subject>Genetic Vectors</subject><subject>Genotype &amp; phenotype</subject><subject>Hepatitis C</subject><subject>Hepatitis C Antibodies - blood</subject><subject>Hepatitis C, Chronic - epidemiology</subject><subject>Hepatitis C, Chronic - immunology</subject><subject>Hepatitis C, Chronic - prevention &amp; control</subject><subject>Humans</subject><subject>Immunogenicity, Vaccine</subject><subject>Incidence</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Laboratories</subject><subject>Lymphocytes T</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Nonstructural proteins</subject><subject>Pan troglodytes</subject><subject>Peptides</subject><subject>Placebos</subject><subject>Ribonucleic acid</subject><subject>RNA</subject><subject>Substance Abuse, Intravenous</subject><subject>T-Lymphocytes - immunology</subject><subject>Vaccine efficacy</subject><subject>Vaccines</subject><subject>Vaccines, Synthetic - immunology</subject><subject>Vaccinia</subject><subject>Viral Hepatitis Vaccines - adverse effects</subject><subject>Viral Hepatitis Vaccines - immunology</subject><subject>Viral infections</subject><subject>Viremia</subject><subject>Young Adult</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp1kE1LAzEQhoMotlaPXiUgHleTnWSzvQhSWqvUD0S9hjQfNqWbaHZb0F_vSqvowbnMYR6eeXkROqTklBJenN0Or2-iykkOwPgW6lIOkDFGim3UJSQvMyb60EF7dT0n7VDW30UdAF4I2ocuGj2oYGLlP6zBj8mrBY4OK_ystPbB4gf74isbcBPxfbIrGxo8mKUYvMbjwTO-Cs7qxsewj3acWtT2YLN76Gk0fByMs8nd5dXgYpJpTmmTFZYTnjvDjODOOW6MsIYKCkJPQTAxdaALBa615qwPQDVjBai8LAtrOJ9CD52vva_LaWWNbgMltZCvyVcqvcuovPx7CX4mX-JKllAI0hp76HgjSPFtaetGzuMyhTazzFlZ5hSoYC2VrSmdYl0n634-UCK_apd_am_5o9-xfujvnlvgZA1UVS2DnVf_iD4BRTmI2Q</recordid><startdate>20210211</startdate><enddate>20210211</enddate><creator>Page, Kimberly</creator><creator>Melia, Michael T</creator><creator>Veenhuis, Rebecca T</creator><creator>Winter, Matthew</creator><creator>Rousseau, Kimberly E</creator><creator>Massaccesi, Guido</creator><creator>Osburn, William O</creator><creator>Forman, Michael</creator><creator>Thomas, Elaine</creator><creator>Thornton, Karla</creator><creator>Wagner, Katherine</creator><creator>Vassilev, Ventzislav</creator><creator>Lin, Lan</creator><creator>Lum, Paula J</creator><creator>Giudice, Linda C</creator><creator>Stein, Ellen</creator><creator>Asher, Alice</creator><creator>Chang, Soju</creator><creator>Gorman, Richard</creator><creator>Ghany, Marc G</creator><creator>Liang, T. Jake</creator><creator>Wierzbicki, Michael R</creator><creator>Scarselli, Elisa</creator><creator>Nicosia, Alfredo</creator><creator>Folgori, Antonella</creator><creator>Capone, Stefania</creator><creator>Cox, Andrea L</creator><general>Massachusetts Medical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3097-0289</orcidid></search><sort><creationdate>20210211</creationdate><title>Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection</title><author>Page, Kimberly ; Melia, Michael T ; Veenhuis, Rebecca T ; Winter, Matthew ; Rousseau, Kimberly E ; Massaccesi, Guido ; Osburn, William O ; Forman, Michael ; Thomas, Elaine ; Thornton, Karla ; Wagner, Katherine ; Vassilev, Ventzislav ; Lin, Lan ; Lum, Paula J ; Giudice, Linda C ; Stein, Ellen ; Asher, Alice ; Chang, Soju ; Gorman, Richard ; Ghany, Marc G ; Liang, T. Jake ; Wierzbicki, Michael R ; Scarselli, Elisa ; Nicosia, Alfredo ; Folgori, Antonella ; Capone, Stefania ; Cox, Andrea L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c511t-6e5052fd4d75fff5dd7ed17137cb3747bf3c6a3ffec249331c4463a2886ed55b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adenoviruses, Simian - genetics</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Adverse events</topic><topic>Allergies</topic><topic>Animals</topic><topic>Chronic infection</topic><topic>Double-Blind Method</topic><topic>Double-blind studies</topic><topic>Enrollments</topic><topic>Female</topic><topic>Genetic Vectors</topic><topic>Genotype &amp; phenotype</topic><topic>Hepatitis C</topic><topic>Hepatitis C Antibodies - blood</topic><topic>Hepatitis C, Chronic - epidemiology</topic><topic>Hepatitis C, Chronic - immunology</topic><topic>Hepatitis C, Chronic - prevention &amp; control</topic><topic>Humans</topic><topic>Immunogenicity, Vaccine</topic><topic>Incidence</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Laboratories</topic><topic>Lymphocytes T</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Nonstructural proteins</topic><topic>Pan troglodytes</topic><topic>Peptides</topic><topic>Placebos</topic><topic>Ribonucleic acid</topic><topic>RNA</topic><topic>Substance Abuse, Intravenous</topic><topic>T-Lymphocytes - immunology</topic><topic>Vaccine efficacy</topic><topic>Vaccines</topic><topic>Vaccines, Synthetic - immunology</topic><topic>Vaccinia</topic><topic>Viral Hepatitis Vaccines - adverse effects</topic><topic>Viral Hepatitis Vaccines - immunology</topic><topic>Viral infections</topic><topic>Viremia</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Page, Kimberly</creatorcontrib><creatorcontrib>Melia, Michael T</creatorcontrib><creatorcontrib>Veenhuis, Rebecca T</creatorcontrib><creatorcontrib>Winter, Matthew</creatorcontrib><creatorcontrib>Rousseau, Kimberly E</creatorcontrib><creatorcontrib>Massaccesi, Guido</creatorcontrib><creatorcontrib>Osburn, William O</creatorcontrib><creatorcontrib>Forman, Michael</creatorcontrib><creatorcontrib>Thomas, Elaine</creatorcontrib><creatorcontrib>Thornton, Karla</creatorcontrib><creatorcontrib>Wagner, Katherine</creatorcontrib><creatorcontrib>Vassilev, Ventzislav</creatorcontrib><creatorcontrib>Lin, Lan</creatorcontrib><creatorcontrib>Lum, Paula J</creatorcontrib><creatorcontrib>Giudice, Linda C</creatorcontrib><creatorcontrib>Stein, Ellen</creatorcontrib><creatorcontrib>Asher, Alice</creatorcontrib><creatorcontrib>Chang, Soju</creatorcontrib><creatorcontrib>Gorman, Richard</creatorcontrib><creatorcontrib>Ghany, Marc G</creatorcontrib><creatorcontrib>Liang, T. Jake</creatorcontrib><creatorcontrib>Wierzbicki, Michael R</creatorcontrib><creatorcontrib>Scarselli, Elisa</creatorcontrib><creatorcontrib>Nicosia, Alfredo</creatorcontrib><creatorcontrib>Folgori, Antonella</creatorcontrib><creatorcontrib>Capone, Stefania</creatorcontrib><creatorcontrib>Cox, Andrea L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Nursing &amp; Allied Health Database</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database (Proquest)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>Biological Sciences</collection><collection>ProQuest Consumer Health Database</collection><collection>ProQuest Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database (ProQuest)</collection><collection>ProQuest Research Library</collection><collection>ProQuest Science Journals</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Page, Kimberly</au><au>Melia, Michael T</au><au>Veenhuis, Rebecca T</au><au>Winter, Matthew</au><au>Rousseau, Kimberly E</au><au>Massaccesi, Guido</au><au>Osburn, William O</au><au>Forman, Michael</au><au>Thomas, Elaine</au><au>Thornton, Karla</au><au>Wagner, Katherine</au><au>Vassilev, Ventzislav</au><au>Lin, Lan</au><au>Lum, Paula J</au><au>Giudice, Linda C</au><au>Stein, Ellen</au><au>Asher, Alice</au><au>Chang, Soju</au><au>Gorman, Richard</au><au>Ghany, Marc G</au><au>Liang, T. Jake</au><au>Wierzbicki, Michael R</au><au>Scarselli, Elisa</au><au>Nicosia, Alfredo</au><au>Folgori, Antonella</au><au>Capone, Stefania</au><au>Cox, Andrea L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>2021-02-11</date><risdate>2021</risdate><volume>384</volume><issue>6</issue><spage>541</spage><epage>549</epage><pages>541-549</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><abstract>In this trial, the safety and efficacy of a recombinant chimpanzee adenovirus 3 vector priming vaccination and a recombinant modified vaccinia Ankara boost was assessed in adults who were at risk for HCV infection because of injection drug use. The vaccine did not cause serious adverse events and did elicit HCV-specific T-cell responses, but it did not prevent chronic HCV infection.</abstract><cop>United States</cop><pub>Massachusetts Medical Society</pub><pmid>33567193</pmid><doi>10.1056/NEJMoa2023345</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-3097-0289</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0028-4793
ispartof The New England journal of medicine, 2021-02, Vol.384 (6), p.541-549
issn 0028-4793
1533-4406
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8367093
source MEDLINE; New England Journal of Medicine Current; EZB Electronic Journals Library
subjects Adenoviruses, Simian - genetics
Adolescent
Adult
Adverse events
Allergies
Animals
Chronic infection
Double-Blind Method
Double-blind studies
Enrollments
Female
Genetic Vectors
Genotype & phenotype
Hepatitis C
Hepatitis C Antibodies - blood
Hepatitis C, Chronic - epidemiology
Hepatitis C, Chronic - immunology
Hepatitis C, Chronic - prevention & control
Humans
Immunogenicity, Vaccine
Incidence
Infections
Infectious diseases
Laboratories
Lymphocytes T
Male
Middle Aged
Nonstructural proteins
Pan troglodytes
Peptides
Placebos
Ribonucleic acid
RNA
Substance Abuse, Intravenous
T-Lymphocytes - immunology
Vaccine efficacy
Vaccines
Vaccines, Synthetic - immunology
Vaccinia
Viral Hepatitis Vaccines - adverse effects
Viral Hepatitis Vaccines - immunology
Viral infections
Viremia
Young Adult
title Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T20%3A06%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Randomized%20Trial%20of%20a%20Vaccine%20Regimen%20to%20Prevent%20Chronic%20HCV%20Infection&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Page,%20Kimberly&rft.date=2021-02-11&rft.volume=384&rft.issue=6&rft.spage=541&rft.epage=549&rft.pages=541-549&rft.issn=0028-4793&rft.eissn=1533-4406&rft_id=info:doi/10.1056/NEJMoa2023345&rft_dat=%3Cproquest_pubme%3E2488213174%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2488213174&rft_id=info:pmid/33567193&rfr_iscdi=true